NIA R01: Drug Repositioning and Combination Therapy for Alzheimer's Disease
Funds researchers combining computational and experimental approaches to test repositioned drugs for Alzheimer's disease treatment through NIH R01 grants.
About
The National Institute on Aging (NIA), part of the National Institutes of Health (NIH) under the Department of Health and Human Services, administers this R01 grant through the PAR-25-374 Notice of Funding Opportunity (NOFO). It sits under the ACTDRx AD (Advancing Combination Therapy and Drug Repurposing for Alzheimer's Disease) program, a cross-disciplinary initiative using translational bioinfor…
AIBiotechMedtechSynthetic Biology
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.